Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis
NCT03113162
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL:
Autologous Hematopoietic Stem Cell
DRUG:
BEAM Regimen
Sponsor
Makati Medical Center